New York State Psychiatric Institute
Clinical trials sponsored by New York State Psychiatric Institute, explained in plain language.
-
Can better sleep slow memory decline? new study investigates
Disease control Not yet recruitingThis study is testing whether improving sleep can help protect memory and thinking skills in older adults who have early signs of memory loss and trouble sleeping. Researchers will compare two different sleep treatments: talk therapy for insomnia and a headband that plays gentle …
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated Apr 02, 2026 07:27 UTC
-
Virtual doctor visits vs clinic appointments: which works better for opioid treatment?
Disease control Not yet recruitingThis study tests whether treating opioid addiction through video calls works as well as traditional in-person clinic visits. 50 people with opioid addiction will receive buprenorphine medication either through telemedicine or at a clinic for 12 weeks. Researchers will compare how…
Phase: PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Can better job support help people with OCD succeed at work?
Symptom relief Not yet recruitingThis study tests two approaches to help adults with obsessive-compulsive disorder (OCD) find and keep jobs. All 40 participants will receive standard OCD therapy, then half will get enhanced job placement support while the other half gets standard vocational services. Researchers…
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC
-
Scientists scan brains to predict psychosis before it strikes
Knowledge-focused Not yet recruitingThis study aims to understand how psychosis develops by looking at brain chemistry in young adults who are at high risk for the condition. Researchers will use special brain scans (PET and MRI) to measure dopamine, a brain chemical linked to psychosis, in 115 participants aged 18…
Phase: PHASE1 • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC
-
Scientists scan brains to unlock mystery of bipolar depression drug
Knowledge-focused Not yet recruitingThis study aims to understand how the medication cariprazine (Vraylar) helps people with bipolar depression. Eight adults with the condition will take the drug and have special brain scans (PET scans) before and during treatment. Researchers will look at how the drug interacts wi…
Phase: PHASE4 • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Scientists scan brains to see if new drug hits target in schizophrenia
Knowledge-focused Not yet recruitingThis study aims to understand how an experimental drug called Cobenfy affects brain chemistry in people with schizophrenia. Twelve participants will receive one of three doses for five weeks and undergo special brain scans before and after treatment. The main goal is to measure i…
Phase: PHASE1, PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC
-
Brain scans & smartphones probe Ketamine's Anti-Suicide effect
Knowledge-focused Not yet recruitingThis study aims to understand how the drug ketamine might help reduce suicidal thoughts in people with major depression. Researchers will use smartphone apps to track daily stress and brain scans to see how ketamine affects specific brain pathways. The goal is to learn more about…
Phase: PHASE4 • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC